Loading clinical trials...

Effect of Low Level Laser Therapy in Patients With Chronic Rhinosinusitis. | Clinical Trials | Clareo Health

COMPLETEDNA

Effect of Low Level Laser Therapy in Patients With Chronic Rhinosinusitis.

Effect of Low Level Laser Therapy on Headache, and Fatigue in Patients With Chronic Rhinosinusitis.

NCT05861817•Cairo University

Summary

This study aimed to evaluate the efficacy of low-level laser therapy (LLLT) for Chronic sinusitis in a randomized, double-blind, placebo-controlled trial.

Detailed Description

Chronic sinusitis, or chronic rhinosinusitis, is an inflammatory condition defined by symptomatic inflammation of the paranasal sinuses lasting longer than 3 months. Common presenting symptoms include nasal obstruction, facial pressure or fullness, nasal discharge (anterior or posterior), and olfactory loss. Furthermore, chronic sinusitis is associated with reductions in patient quality of life (QOL), sleep quality, and daily productivity. It has been suggested that low-level laser can be used in treating chronic sinusitis but there are limited studies about its usage. HYPOTHESES: There is no statistically significant effect of laser therapy on headache, fatigue, or CT finding in patients with chronic sinusitis.

Eligibility

Age

19 - 40 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•patients suffering from mild to moderate symptoms.

Exclusion Criteria

•Pregnant or breastfeeding women
•Patients with a definite deviated nasal septum, sinusitis, or history of operation within the last 6 months.
•Patients with hypertension, diabetes mellitus, malignancy, active pulmonary tuberculosis, infection, active respiratory disease like asthma, or other systemic diseases; • patients with long-term use of corticosteroids or immunosuppressive agents.
•Patients with hypersensitivity to the laser.
•Patients who were involved in another clinical study within 30 days.
•Patients who were unable to comply with the follow-up schedules.
•patients who had used antihistamines within 1 week, topical corticosteroids within2 weeks, systemic corticosteroids within 4 weeks, anti-cholinergic drugs within 3 days, antileukotriene drugs within 1 week, decongestants within 3 days, tricyclic antidepressants or phenothiazines within 2 weeks, non-steroidal analgesics within 2 weeks, and other drugs whi

Locations (2)

Faculty of physical therapy, Cairo university

Giza, Dokki, Egypt

Olfat Ibrahim Ali

Giza, Dokki, Egypt

Key Dates

Start Date

January 18, 2022

Primary Completion Date

February 1, 2023

Completion Date

February 1, 2023

Last Updated

May 17, 2023

Enrollment

ACTUAL participants

Conditions

RhinosinusitisHeadacheFatigueCT

Interventions

Laser theapy

DEVICE

Mind Body Balance for Pediatric Migraine

NCT04715685

HeadacheHeadache Disorders+6 more

View study

RECRUITINGNA

MyVitalC: Sleep and Everyday Headache Management

NCT07477236

SleepHeadaches

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 17, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of Low Level Laser Therapy in Patients With Chronic Rhinosinusitis.

Inclusion Criteria

Exclusion Criteria

Mind Body Balance for Pediatric Migraine

MyVitalC: Sleep and Everyday Headache Management

Light Exposure, Migraine Outcomes, and Sleep Quality

Improving Post COVID-19 Syndrome With Hyperbaric Oxygen Treatments

Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Study

Cognitive Performance, Sleep Disturbances and Fatigue in Multiple Sclerosis